Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Internal Medicine (Tokyo, Japan)|September 1, 2004
Paraneoplastic cerebellar degeneration (PCD) associated with squamous cell carcinoma of the lungJun Konishi, Koichi Yamazaki, Kanako Chikai, et al.
Cancer Science|November 13, 2003
CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancersOsamu Wakabayashi, Koichi Yamazaki, Satoshi Oizumi, et al.
Anticancer Research|January 30, 2003
Topoisomerase inhibitor-induced apoptosis accompanied by down-regulation of Bcl-2 in human lung cancer cellsSatoshi Oizumi, Hiroshi Isobe, Shigeaki Ogura, et al.
Oncology|July 26, 2002
RCAS1 expression: a potential prognostic marker for adenocarcinomas of the lungSatoshi Oizumi, Koichi Yamazaki, Manabu Nakashima, et al.
Pulmonary Pharmacology & Therapeutics|December 9, 2008
Concentrations of clarithromycin and active metabolite in the epithelial lining fluid of patients with Mycobacterium avium complex pulmonary diseaseNaoki Hasegawa, Tomoyasu Nishimura, Masazumi Watabnabe, et al.
International Journal of Oncology|June 15, 2006
Elevated pleural fluid RCAS1 is a diagnostic marker and outcome predictor in lung cancer patientsKeisuke Aoe, Akio Hiraki, Koichi Yamazaki, et al.
Cancer Immunology, Immunotherapy : CII|July 14, 2007
Immunotherapy with dendritic cells pulsed with tumor-derived gp96 against murine lung cancer is effective through immune response of CD8+ cytotoxic T lymphocytes and natural killer cellsNaofumi Shinagawa, Koichi Yamazaki, Yasuaki Tamura, et al.
Cancer Science|January 19, 2008
Anti-OX40 monoclonal antibody therapy in combination with radiotherapy results in therapeutic antitumor immunity to murine lung cancerHiroshi Yokouchi, Koichi Yamazaki, Kenji Chamoto, et al.
Cancer Immunity|August 30, 2008
Prolonged survival of patients with lung adenocarcinoma expressing XAGE-1b and HLA class I antigensEiki Kikuchi, Koichi Yamazaki, Eiichi Nakayama, et al.
Cancer Science|January 31, 2006
Tetramer-blocking assay for defining antigen-specific cytotoxic T lymphocytes using peptide-MHC tetramerHiroshi Yokouchi, Kenji Chamoto, Daiko Wakita, et al.
Pageof 7